TH — Theratechnologies Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$86.90m
- CA$115.39m
- $81.76m
- 54
- 65
- 15
- 41
2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | 2023 November 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -12.5 | -22.7 | -31.7 | -47.2 | -24 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 5.27 | 6.87 | 8.26 | 11.3 | 15.2 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3.66 | -6.27 | 0.242 | 8.73 | -0.241 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -3.39 | -13.6 | -14.5 | -14.7 | -5.68 |
Capital Expenditures | -3.62 | -0.032 | -0.166 | -0.985 | -1.82 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 3.49 | 4.81 | -12.3 | 9.67 | 2.93 |
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.13 | 4.78 | -12.5 | 8.68 | 1.11 |
Financing Cash Flow Items | -3.42 | -3.31 | -7.15 | -3.97 | -2.48 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -6.81 | -7.23 | 34.6 | 9.66 | 14.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -10.3 | -15.9 | 7.66 | 3.46 | 10.2 |